Anders Hove joined Venrock in 2004. He sits on several private company Boards, including Intuity Medical and Impopharma. In 2011, Anders was named to Forbes’ Midas List, which ranks the top venture capitalists in life sciences and technology.
Prior to Venrock, Anders held senior level positions in the medical, clinical and business operations of the pharmaceuticals division of Ciba-Geigy, and later as the portfolio manager of BB Biotech and CEO of Bellevue Asset Management. At Bellevue, Anders had responsibility for managing BB Biotech, an investment company with several billion dollar invested in public and private biotech companies. While at BB Biotech, Anders led numerous public and private investments.
Anders earned his M.Sc. in Biotechnology Engineering from the Technical University of Denmark, his M.D. at the University of Copenhagen and an M.B.A. from INSEAD.